4//SEC Filing
Turtle Cameron 4
Accession 0000950170-24-017494
CIK 0001636282other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 9:21 PM ET
Size
5.1 KB
Accession
0000950170-24-017494
Insider Transaction Report
Form 4
Turtle Cameron
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2024-02-15$9.82/sh+400$3,928→ 746,907 total
Footnotes (2)
- [F1]These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]Includes 493,558 shares of common stock that vest over an approximately three year period, subject to the continuing service of the Reporting Person on each vesting date.
Documents
Issuer
Spyre Therapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001758363
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 9:21 PM ET
- Size
- 5.1 KB